This inventor holds 31 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Alzheimer's Disease Research. Top assignees: The General Hospital Corporation, University of California, Columbia University. Active years: 1996-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Canton, MA (US) (1996 - 2005)
- Charlestown, MA (US) (2016 - 2018)
- Hull, MA (US) (2002 - 2021)
- Cohasset, MA (US) (2018 - 2021)
- Milton, MA (US) (2023)
Company Filing History:
29 out of 3,076 
4 out of 16,035 
2 out of 2,560 
Years Active: 1996-2025
Areas of Expertise:
Title: Rudolph Emile Tanzi: Pioneering Innovations in Neurodegenerative Disease Research
Introduction
Rudolph Emile Tanzi is a prominent inventor and researcher based in Hull, MA, USA. With an impressive portfolio of 30 patents, his contributions to the field of neurodegenerative diseases have significantly advanced the understanding and treatment of conditions like Alzheimer's, Parkinson's, and Huntington's disease.
Latest Patents
Two of his most recent patents demonstrate his commitment to addressing neuro-inflammation related to neurodegenerative diseases. The first patent focuses on "Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases," outlining methods to treat neuron inflammation conditions by administering a therapeutically effective amount of cromolyn or its derivatives. The second patent, "Potent gamma-secretase modulators," presents compounds and methods targeted at treating disorders linked to aberrant Aβ peptide levels, including Alzheimer's disease.
Career Highlights
Throughout his career, Rudolph Tanzi has held pivotal positions at influential institutions, notably at The General Hospital Corporation and the University of California. His work has garnered recognition from peers and has considerably influenced neuroscience research.
Collaborations
Tanzi has collaborated with esteemed colleagues, including Ashley I. Bush and Robert D. Moir. These collaborations have led to significant advancements in the understanding of neurodegenerative diseases and the mechanisms driving them.
Conclusion
Rudolph Emile Tanzi's innovative work and numerous patents reflect his dedication to finding solutions for neurodegenerative diseases. Through his research and collaboration with top professionals, he continues to make strides in improving therapeutic approaches and enhancing the quality of life for those affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile